SYNJ1 Protein

SYNJ1 Protein

Introduction

Synj1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@krebs2013]
<table> [@cremona1999]
<tr><th colspan="2">SYNJ1 Protein</th></tr> [@mani2007]
<tr><td>Protein Name</td><td>Synaptojanin 1</td></tr> [@cao2017]
<tr><td>Gene</td><td>[SYNJ1](/genes/synj1)</td></tr>
<tr><td>UniProt</td><td>[Q9YFZ1](https://www.uniprot.org/uniprot/Q9YFZ1)</td></tr>
<tr><td>Molecular Weight</td><td>175 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Presynaptic terminal, endocytic zone</td></tr>
<tr><td>Protein Family</td><td>Synaptojanin family (inositol 5-phosphatases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">41 edges</a></td>
</tr>
</table>
</div>

Overview

...

SYNJ1 Protein

Introduction

Synj1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@krebs2013]
<table> [@cremona1999]
<tr><th colspan="2">SYNJ1 Protein</th></tr> [@mani2007]
<tr><td>Protein Name</td><td>Synaptojanin 1</td></tr> [@cao2017]
<tr><td>Gene</td><td>[SYNJ1](/genes/synj1)</td></tr>
<tr><td>UniProt</td><td>[Q9YFZ1](https://www.uniprot.org/uniprot/Q9YFZ1)</td></tr>
<tr><td>Molecular Weight</td><td>175 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Presynaptic terminal, endocytic zone</td></tr>
<tr><td>Protein Family</td><td>Synaptojanin family (inositol 5-phosphatases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">41 edges</a></td>
</tr>
</table>
</div>

Overview

SYNJ1 (Synaptojanin 1) is a presynaptic phosphoinositide phosphatase essential for synaptic vesicle recycling. It functions as a key regulator of phosphoinositide metabolism at the synapse, dephosphorylating PI(4,5)P₂ and PI(3,4,5)P₃ to regulate clathrin-mediated endocytosis. Dominant mutations in SYNJ1 cause early-onset Parkinson's disease, while recessive mutations cause a severe neurodevelopmental disorder with Parkinsonism, linking synaptic lipid signaling to neurodegeneration^[1].

Structure

SYNJ1 contains multiple functional domains:

N-terminal Sac1 Domain: Catalytic domain with PI(4)P phosphatase activity

Central 5-Phosphatase Domain: Primary catalytic domain for PI(4,5)P₂ and PI(3,4,5)P₃

Proline-Rich Region: Binds to SH3 domain-containing proteins including endophilins

C-terminal Domain: Involved in membrane association and interactions

Normal Function

SYNJ1 is crucial for synaptic vesicle cycling:

PI(4,5)P₂ Metabolism: Regulates phosphoinositide composition of the presynaptic membrane

Clathrin Uncoating: Dephosphorylates PI(4,5)P₂ on clathrin-coated vesicles

Endocytic Zone Organization: Forms a specialized endocytic zone adjacent to active zones

Synaptic Vesicle Recycling: Ensures rapid reavailability of synaptic vesicles

Molecular Mechanism

SYNJ1 operates in the synaptic vesicle cycle:

Vesicle Endocytosis: After fusion, PI(4,5)P₂ marks clathrin-coated pits

Uncoating Initiation: SYNJ1 dephosphorylates PI(4,5)P₂ to PI(4)P

Clathrin Dissociation: Loss of PI(4,5)P₂ promotes clathrin removal

Vesicle Reformation: Dephosphorylated membrane can re-enter the cycle

Role in Disease

Early-Onset Parkinson's Disease

Dominant SYNJ1 mutations cause familial PD:

• R258Q Mutation: Impairs 5-phosphatase activity^[2]
• Parkinsonism: Early-onset (age 20-40), progressive
• Dementia: Cognitive decline in some patients
• Brain Iron Accumulation: MRI shows iron deposition

Neurodevelopmental Disorder with Parkinsonism

Recessive SYNJ1 mutations cause:

• Early-onset seizures
• Developmental delay
• Hypotonia
• Later-onset Parkinsonism
• Cortical atrophy

Mechanisms of Neurodegeneration

Impaired Vesicle Recycling: Accumulation of clathrin-coated vesicles

Synaptic Dysfunction: Reduced vesicle availability

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Aggregation: Altered endocytic pathways

Neuronal Energy Deficit: Compromised neurotransmitter release

Therapeutic Approaches

Strategies targeting SYNJ1-related pathways:

Phosphoinositide Modulators: Small molecules to enhance PI(4,5)P₂ metabolism

Gene Therapy: AAV-mediated wild-type SYNJ1 expression

Endocytic Pathway Enhancers: Supporting alternative vesicle recycling

Neuroprotective Agents: Supporting synaptic function

Research Directions

Active research areas include:

• Understanding how PD mutations disrupt SYNJ1 function
• Developing brain-penetrant phosphoinositide modulators
• Links between SYNJ1 and [alpha-synuclein](/proteins/alpha-synuclein) pathology
• Biomarkers for synaptic dysfunction in PD

Background

The study of Synj1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• SYNJ1 Gene
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction)
• [Alpha-Synuclein Aggregation Pathway](/mechanisms/alpha-synuclein-pathology)
• [Synaptic Vesicle Proteins](/content/proteins)
• Endocytosis

External Links

• [UniProt: SYNJ1](https://www.uniprot.org/uniprot/Q9YFZ1)
• [GeneCards: SYNJ1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYNJ1)
• [OMIM: SYNJ1](https://www.omim.org/entry/604297)

Expression Pattern

SYNJ1 exhibits distinct expression patterns in the nervous system:

Brain Regional Distribution

• High expression: Cerebral cortex (layer 5), hippocampus (CA1, dentate gyrus), basal ganglia
• Moderate expression: Cerebellum (Purkinje cells), brainstem
• Cellular localization: Enriched in presynaptic terminals, dendritic spines

Subcellular Localization

• Synaptic vesicles: Concentrated on synaptic vesicle membranes
• Presynaptic active zone: Colocalizes with SV2A, synaptophysin
• Endocytic zones: Co-localizes with clathrin, dynamin
• Dendritic compartments: Postsynaptic spine enrichment

Developmental Regulation

• Expression increases during postnatal development
• Peaks during synaptogenesis
• Maintained in adult brain

Molecular Interactions

Protein-Protein Interactions

| Partner | Interaction Type | Function |
|---------|-----------------|----------|
| Synaptojanin-1 | Self-dimerization | Oligomerization |
| Endophilin | Binding | Membrane curvature |
| Dynamin | Coordination | Fission regulation |
| Synapsin | Co-localization | Vesicle clustering |
| RAB5 | Regulatory | Early endosome function |

Lipid Interactions

• Phosphatidylinositol-4,5-bisphosphate (PIP2) binding
• Phosphatidylinositol-3,4,5-trisphosphate (PIP3) regulation
• Membrane lipid composition effects on activity

Animal Models

Mouse Models

• Synj1 knockout: Embryonic lethal, severe neurological defects
• Conditional knockout: Synaptic vesicle recycling impairment
• Point mutations: Parkinson's disease-like phenotypes

Zebrafish Studies

• Synj1 knockdown: Developmental abnormalities
• Rescue experiments: Functional validation

In vitro Models

• Neuronal cultures from patient iPSCs
• CRISPR-corrected isogenic lines

Therapeutic Strategies

| Approach | Mechanism | Development Stage |
|----------|-----------|-------------------|
| Gene therapy | AAV-delivered wild-type SYNJ1 | Preclinical |
| Small molecules | Enhance synaptic vesicle cycling | Discovery |
| Protein replacement | Delivery of functional protein | Research |
| Neuroprotective agents | Target downstream pathways | Clinical trials |

Biomarkers

• SYNJ1 mRNA in blood: Parkinson's disease biomarker potential
• SYNJ1 protein in CSF: Neurodegeneration marker
• Phospho-SYNJ1: Disease progression indicator

Research Directions

[^[^

References

[Quadri M, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24261939/))

[Krebs CE, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24240609/))

[Cremona O, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10535921/))

[Mani M, et al, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17568663/))

[Cao M, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28715556/))

Pathway Diagram

The following diagram shows the key molecular relationships involving SYNJ1 Protein discovered through SciDEX knowledge graph analysis: